EBS Operating Cash Flow (Statement)
Emergent Biosolutions Inc · Operating Cash Flow (Statement)
EBS Operating Cash Flow (Statement)
Latest reported$97.70Mperiod ending
EBS Cash from Operations ($321.10M → $97.70M)
Annual operating cash flow (statement)
High-resolution chart · PNG
EBS operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 170,600,000 | |
| 58,700,000 | |
| -206,300,000 | |
| -34,100,000 | |
| 321,100,000 | |
| 536,900,000 | |
| 188,000,000 | |
| 41,800,000 | |
| 208,139,000 | |
| 53,487,000 | |
| 44,459,000 | |
| 112,318,000 | |
| 96,968,000 | |
| 39,643,000 | |
| 14,593,000 | |
| 99,543,000 | |
| 30,511,000 | |
| 7,317,000 | |
| 55,447,000 | |
| -4,061,000 | |
| 42,250,000 | |
| 9,196,000 | |
| 321,100,000 |